Short Subjects
Nienke Soeters, BOptom; Allegonda Van der Lelij, MD, PhD; Rikkert van der Valk, MD, MSc, PhD; Nayyirih G. Tahzib, MD, PhD, FEBOphth
- Journal of Pediatric Ophthalmology and Strabismus
-
DOI: 10.3928/01913913-20110614-02
Abstract
The authors describe four children with progressive keratoconus treated by corneal crosslinking (CXL). The current CXL guidelines recommend treatment of patients 18 years and older. Nevertheless, keratoconus can rapidly progress in young teenagers. CXL could be a safe procedure to prevent a keratoplasty at a young age.
AUTHORS
From the Utrecht Cornea Research Group, Department of Ophthalmology, University Medical Center Utrecht, Utrecht, The Netherlands.
The authors have no financial or proprietary interest in the materials presented herein.
Address correspondence to Nineke Soeters, BOptom, Department of Ophthalmology, HP E03.136, University Medical Center Utrecht, Heidelberglaan 100, 3508 GX Utrecht, The Netherlands. E-mail: N.Soeters@umcutrecht.nl
doi: 10.3928/01913913-20110614-02